Literature DB >> 12888047

Vitreous hemorrhage in patients with high-risk retinopathy of prematurity.

Kelly A Hutcheson1, Ahn T Q Nguyen, Mark W Preslan, Nancy J Ellish, Scott M Steidl.   

Abstract

PURPOSE: To investigate outcomes in premature infants with high-risk retinopathy of prematurity and secondary vitreous hemorrhage.
DESIGN: Retrospective chart review.
METHODS: Patients were selected from a database of infants undergoing retinopathy of prematurity screening from September 1997 to November 1999. Infants with high-risk retinopathy of prematurity (zone I or posterior zone II threshold disease) with and without vitreous hemorrhage were compared. MAIN OUTCOME MEASURES: Final stage of retinopathy of prematurity and short-term structural outcome were assessed. Visual acuity and refraction were measured when possible.
RESULTS: Twenty-two eyes of 11 patients (group 1) had high-risk (posterior zone II or zone I threshold) retinopathy of prematurity without vitreous hemorrhage. Group 1 patients had a 91% favorable short-term structural outcome. Eight eyes of five infants developed vitreous hemorrhage with high-risk retinopathy of prematurity (group 2). Group 2 patients had only a 12.5% favorable short-term structural outcome. Seven of eight (87.5%) progressed to stage IVa or IVb retinopathy of prematurity. Six eyes underwent vitreoretinal surgery after a median duration of hemorrhage of 36 +/- 29 days (4-70 days). Three eyes developed stage V detachments and three progressed to phthisical degeneration. Final visual acuity was no light perception in three eyes.
CONCLUSION: Vitreous hemorrhage, in association with advanced retinopathy of prematurity, is a poor prognostic sign.

Entities:  

Mesh:

Year:  2003        PMID: 12888047     DOI: 10.1016/s0002-9394(03)00190-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Retinal haemorrhages in a preterm infant following screening examination for retinopathy of prematurity.

Authors:  Z Lim; N N Tehrani; A V Levin
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

2.  Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.

Authors:  Ramak Roohipoor; Hamed Ghasemi; Fariba Ghassemi; Reza Karkhaneh; Mohammad Riazi-Esfahani; Mehdi Nili-Ahmadabadi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

3.  Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.

Authors:  Ebenezer Daniel; Gui-Shuang Ying; R Michael Siatkowski; Wei Pan; Eli Smith; Graham E Quinn
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

4.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 5.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

6.  Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.

Authors:  Hossein Nazari; Mehdi Modarres; Mohammad Mehdi Parvaresh; Khalil Ghasemi Falavarjani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-27       Impact factor: 3.117

7.  Lens-sparing vitrectomy for stage 4 and stage 5 retinopathy of prematurity.

Authors:  Young Suk Yu; Seong-Joon Kim; So Young Kim; Ho Kyung Choung; Gyu Hyung Park; Jang Won Heo
Journal:  Korean J Ophthalmol       Date:  2006-06

8.  An inhibitor of endothelial ETS transcription factors promotes physiologic and therapeutic vessel regression.

Authors:  Christopher M Schafer; Jami M Gurley; Katarzyna Kurylowicz; Prisca K Lin; Wen Chen; Michael H Elliott; George E Davis; Faizah Bhatti; Courtney T Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

9.  Characteristics and outcomes of anterior hyaloidal fibrovascular proliferation in lasered retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Study (ITCROPS) report number 4.

Authors:  Vivek Pravin Dave; Subhadra Jalali; Padmaja Kumari Rani; Tapas Ranjan Padhi
Journal:  Int Ophthalmol       Date:  2013-09-14       Impact factor: 2.031

Review 10.  Surgical management of retinopathy of prematurity.

Authors:  G Baker Hubbard
Journal:  Curr Opin Ophthalmol       Date:  2008-09       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.